| | Volume 44,Issue 12,2025 Table of ContentsDownload Contents
Experimental Research | | | Study of Chidan Tuihuang Granules alleviating ANIT-induced cholestasis by inhibiting apoptosis signaling pathway | | | ZENG Lingshun, SHI Senpan, WANG Yile, TAN Lingzhi, TAN Xiyue, FU Lingping, ME Xiao | | | Published December 25, 2025 | | | 2025,44(12):1145-1152,1179 [Abstract(2418)] [View PDF 5.22 M (737)] | | | | | Analysis of quality markers of Xiaoxianxiong Decoction in the interventionof prediabetes based on fingerprint, chemometricsand network pharmacology | | | XIE Yan, DENG Shiren, CAO Yifan, LI Hanyue, ZOU Ye, XIA Linbo | | | Published December 25, 2025 | | | 2025,44(12):1153-1160 [Abstract(2131)] [View PDF 3.79 M (773)] | | | | | Chemical constituents and their anti-inflammatory activities of Acanthopanacis Cortex | | | ZHANG Xue1,2, BAI Cuihui1, NIU Wenshan3, DU Yujie1, LI Yuwei1, MA Yexue1, GUO Dongxiao4, LIN Yongqiang4, LIU Qingzhi1, XU Lili5 | | | Published December 25, 2025 | | | 2025,44(12):1161-1164,1199 [Abstract(2254)] [View PDF 1.68 M (774)] | | | | | Research on the immunomodulatory effects of Shenbai Nanosuspension in immunocompromised mice | | | ZHANG Yi1, CHEN Yin1, ZHANG Honglei1, LIU Weiting2, LIU Yongguo1, LI Xiaodong2 | | | Published December 25, 2025 | | | 2025,44(12):1165-1172 [Abstract(2128)] [View PDF 1.64 M (778)] | | | | | Exploration on the mechanism of Tibetan Medicine Ershiwu Wei Guijiu Pill in preventing postmenopausal osteoporosis based on transcriptomics | | | LI Changxing1, YU Yao2, ZHANG Lixue3, MA Lina1, YANG Aiping4 | | | Published December 25, 2025 | | | 2025,44(12):1173-1179 [Abstract(2287)] [View PDF 3.14 M (778)] | | | | | Mechanism of tumor inhibition of tetrahydrocurcumin on S180 tumor bearing mice and non clinical safety study of different formulations | | | ZANG Bo1, WANG Li1, ZANG Junyi2, ZHAN Lingqing3 | | | Published December 25, 2025 | | | 2025,44(12):1180-1187 [Abstract(2304)] [View PDF 1.75 M (746)] | | | |
Review | | | Pertussis and current status of pertussis vaccine development | | | KONG Ruifang 1,2, LIN Ang1,2 | | | Published December 25, 2025 | | | 2025,44(12):1200-1207 [Abstract(2333)] [View PDF 1.70 M (713)] | | | | | Research progress of traditional Chinese medicine intervention in liver injury induced by valproic acid and its salts | | | BAI Wanquan, DILIREBA·Aimaier, MAIERZIYA·Maimaitituxun, ZHANG Le | | | Published December 25, 2025 | | | 2025,44(12):1208-1215 [Abstract(2325)] [View PDF 1.66 M (733)] | | | | | 依拉环素联合用药对抗碳青霉烯类耐药革兰阴性菌的研究进展 | | | FENG Anlong1, WANG Shuang2, FENG Rui3, WANG Ting3, CAO Yan3, WU Jiyong1,3, CAI Meichao1 | | | Published December 25, 2025 | | | 2025,44(12):1216-1223 [Abstract(2255)] [View PDF 1.70 M (809)] | | | | | Research progress on nanomedicines release testing methods | | | SUN Jiabei1, PENG Bo2, LIN Xiaoyang3, WU Jun2, HUANG Haiwei1 | | | Published December 25, 2025 | | | 2025,44(12):1224-1231,1244 [Abstract(2267)] [View PDF 1.39 M (777)] | | | | | Research progress in hydrogel matrix tablets | | | XI Chenchen, LIU Mengsi, ZHANG Zhongheng | | | Published December 25, 2025 | | | 2025,44(12):1232-1239 [Abstract(2216)] [View PDF 1.22 M (813)] | | | |
Pharmaceutical Education Adverse Drug Reactions New Drug Registration and Evaluation Technology | | | Overview and reflections on the drug registration management systems of China, the United States, Japan and European Union | | | DING Xiaoli, LI Mengjiao, TAN Liyuan, YAO Shangchen, CHEN Hua, SUN Huimin | | | Published December 25, 2025 | | | 2025,44(12):1188-1193 [Abstract(2211)] [View PDF 1.17 M (796)] | | | | | The key points and common problem analysis for pharmaceuticalresearch and development of biological products | | | ZHANG Pin1, SONG Kai2 | | | Published December 25, 2025 | | | 2025,44(12):1194-1199 [Abstract(2408)] [View PDF 1.37 M (881)] | | | |
|